Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|December 10, 2021
Changes in Thyroid Hormone Signaling Mediate Cardiac Dysfunction in the Tg197 Mouse Model of Arthritis: Potential Therapeutic ImplicationsLydia Ntari, Polyxeni Mantzouratou, Athanasia Katsaouni, et al.
Hepatology (Baltimore, Md.)|August 27, 2021
Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseasesAdriana Psaraki, Lydia Ntari, Christos Karakostas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 16, 2024
A Novel Human Interleukin-23A Overexpressing Mouse Model of Systemic Lupus ErythematosusEleni Christodoulou-Vafeiadou, Christina Geka, Lida Iliopoulou, et al.
Annals of the Rheumatic Diseases|February 25, 2018
Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesisLydia Ntari, Maria Sakkou, Panagiotis Chouvardas, et al.
Mechanisms of Ageing and Development|August 9, 2023
Targeting senescence and inflammation in chronic destructive TNF-driven joint pathologyNikolaos I Vlachogiannis, Konstantinos Evangelou, Lydia Ntari, et al.
Journal of Translational Medicine|April 24, 2021
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatmentLydia Ntari, Christoforos Nikolaou, Ksanthi Kranidioti, et al.
JCI Insight|April 6, 2018
Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosisMaria Sakkou, Panagiotis Chouvardas, Lydia Ntari, et al.
Cancers|August 12, 2023
Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel TherapeuticsAnthi Kolokotroni, Evi Gkikopoulou, Vagelis Rinotas, et al.
Arthritis Research & Therapy|October 7, 2020
Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritisEleni Christodoulou-Vafeiadou, Christina Geka, Lydia Ntari, et al.
JCI Insight|April 4, 2023
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritisDimitra Papadopoulou, Fani Roumelioti, Christos Tzaferis, et al.
Pageof 2